Panagiotis Tsourapas - 03 May 2023 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Issuer symbol
CL
Transactions as of
03 May 2023
Net transactions value
-$433,344
Form type
4
Filing time
05 May 2023, 16:24:36 UTC
Previous filing
21 Feb 2023
Next filing
12 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $2,555,000 +35,000 +507% $73.00 41,906 03 May 2023 Direct F1
transaction CL Common Stock Sale $2,832,746 -35,000 -84% $80.94 6,906 03 May 2023 Direct F2, F3
transaction CL Common Stock Options Exercise $1,460,000 +20,000 +290% $73.00 26,906 04 May 2023 Direct F1
transaction CL Common Stock Sale $1,615,598 -20,000 -74% $80.78 6,906 04 May 2023 Direct F2, F4
holding CL Common Stock 4,141 03 May 2023 By Issuer's 401(k) Plan Trustee
holding CL Common Stock 3,226 03 May 2023 By Spouse
holding CL Common Stock 59,282 03 May 2023 By Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -35,000 -51% $0.000000 33,698 03 May 2023 Common Stock 35,000 $73.00 Direct F1, F6
transaction CL Stock Option (Right to Buy) Options Exercise $0 -20,000 -59% $0.000000 13,698 04 May 2023 Common Stock 20,000 $73.00 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.7388 to $81.1000, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.7700 to $80.8100, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 This amount includes 6,223 shares that were previously reported as directly beneficially owned.
F6 Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.